APO Research
Talk to an analyst

APO RESEARCH · REPORT

PCSK9 Targeted Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global PCSK9 Targeted Drugs Industry Growth and Trends Forecast to 2032

27 December 202596 pages

Choose your research edition.

Industry ResearchPCSK9 Targeted Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal PCSK9 Targeted Drugs Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal PCSK9 Targeted Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PCSK9 Targeted Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal PCSK9 Targeted Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global PCSK9 Targeted Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for PCSK9 Targeted Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for PCSK9 Targeted Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PCSK9 Targeted Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of PCSK9 Targeted Drugs include Amgen, Regeneron Pharmaceuticals, Novartis, Sanofi and Innovent Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global PCSK9 Targeted Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The PCSK9 Targeted Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global PCSK9 Targeted Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to PCSK9 Targeted Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global PCSK9 Targeted Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

PCSK9 Targeted Drugs Market by Company

Amgen

Regeneron Pharmaceuticals

Novartis

Sanofi

Innovent Biologics

PCSK9 Targeted Drugs Segment by Type

Inclisiran

Evolocumab

Tafolecimab

Alirocumab

PCSK9 Targeted Drugs Segment by Application

Hypercholesterolemia

Combined Hyperlipidemia

Heart Disease and Stroke Prevention

Other

PCSK9 Targeted Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PCSK9 Targeted Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PCSK9 Targeted Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PCSK9 Targeted Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PCSK9 Targeted Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of PCSK9 Targeted Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inclisiran Table 2. Major Company of Evolocumab Table 3. Major Company of Tafolecimab Table 4. Major Company of Alirocumab Table 5. Global PCSK9 Targeted Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global PCSK9 Targeted Drugs Sales by Type (2021-2026) & (K Units) Table 7. Global PCSK9 Targeted Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global PCSK9 Targeted Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global PCSK9 Targeted Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global PCSK9 Targeted Drugs Price by Type (2021-2026) & (US$/Unit) Table 11. Global PCSK9 Targeted Drugs Sales by Type (2027-2032) & (K Units) Table 12. Global PCSK9 Targeted Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global PCSK9 Targeted Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global PCSK9 Targeted Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global PCSK9 Targeted Drugs Price by Type (2027-2032) & (US$/Unit) Table 16. North America PCSK9 Targeted Drugs Sales by Type (2021-2026) & (K Units) Table 17. North America PCSK9 Targeted Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe PCSK9 Targeted Drugs Sales by Type (2021-2026) & (K Units) Table 19. Europe PCSK9 Targeted Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific PCSK9 Targeted Drugs Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific PCSK9 Targeted Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America PCSK9 Targeted Drugs Sales by Type (2021-2026) & (K Units) Table 23. Latin America PCSK9 Targeted Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa PCSK9 Targeted Drugs Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa PCSK9 Targeted Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. PCSK9 Targeted Drugs Industry Trends Table 27. PCSK9 Targeted Drugs Industry Drivers Table 28. PCSK9 Targeted Drugs Industry Opportunities and Challenges Table 29. PCSK9 Targeted Drugs Industry Restraints Table 30. Global PCSK9 Targeted Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global PCSK9 Targeted Drugs Revenue Market Share by Company (2021-2026) Table 32. Global PCSK9 Targeted Drugs Sales by Company (2021-2026) & (K Units) Table 33. Global PCSK9 Targeted Drugs Sales Share by Company (2021-2026) Table 34. Global PCSK9 Targeted Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global PCSK9 Targeted Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global PCSK9 Targeted Drugs Major Company Production Sites and Headquarters Table 37. Global PCSK9 Targeted Drugs Company, Product Type & Application Table 38. Global PCSK9 Targeted Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global PCSK9 Targeted Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global PCSK9 Targeted Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global PCSK9 Targeted Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global PCSK9 Targeted Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global PCSK9 Targeted Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global PCSK9 Targeted Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global PCSK9 Targeted Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global PCSK9 Targeted Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global PCSK9 Targeted Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global PCSK9 Targeted Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global PCSK9 Targeted Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global PCSK9 Targeted Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global PCSK9 Targeted Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global PCSK9 Targeted Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global PCSK9 Targeted Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global PCSK9 Targeted Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global PCSK9 Targeted Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global PCSK9 Targeted Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global PCSK9 Targeted Drugs Sales by Application (2027-2032) & (K Units) Table 59. Global PCSK9 Targeted Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global PCSK9 Targeted Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global PCSK9 Targeted Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global PCSK9 Targeted Drugs Price by Application (2027-2032) & (US$/Unit) Table 63. North America PCSK9 Targeted Drugs Sales by Application (2021-2026) & (K Units) Table 64. North America PCSK9 Targeted Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe PCSK9 Targeted Drugs Sales by Application (2021-2026) & (K Units) Table 66. Europe PCSK9 Targeted Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific PCSK9 Targeted Drugs Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific PCSK9 Targeted Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America PCSK9 Targeted Drugs Sales by Application (2021-2026) & (K Units) Table 70. Latin America PCSK9 Targeted Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa PCSK9 Targeted Drugs Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa PCSK9 Targeted Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Amgen Company Information Table 74. Amgen Business Overview Table 75. Amgen PCSK9 Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Amgen PCSK9 Targeted Drugs Product Portfolio Table 77. Amgen Recent Development Table 78. Regeneron Pharmaceuticals Company Information Table 79. Regeneron Pharmaceuticals Business Overview Table 80. Regeneron Pharmaceuticals PCSK9 Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Regeneron Pharmaceuticals PCSK9 Targeted Drugs Product Portfolio Table 82. Regeneron Pharmaceuticals Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis PCSK9 Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Novartis PCSK9 Targeted Drugs Product Portfolio Table 87. Novartis Recent Development Table 88. Sanofi Company Information Table 89. Sanofi Business Overview Table 90. Sanofi PCSK9 Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sanofi PCSK9 Targeted Drugs Product Portfolio Table 92. Sanofi Recent Development Table 93. Innovent Biologics Company Information Table 94. Innovent Biologics Business Overview Table 95. Innovent Biologics PCSK9 Targeted Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Innovent Biologics PCSK9 Targeted Drugs Product Portfolio Table 97. Innovent Biologics Recent Development Table 98. North America PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 99. North America PCSK9 Targeted Drugs Sales by Country (2021-2026) & (K Units) Table 100. North America PCSK9 Targeted Drugs Sales Market Share by Country (2021-2026) Table 101. North America PCSK9 Targeted Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 102. North America PCSK9 Targeted Drugs Sales Market Share Forecast by Country (2027-2032) Table 103. North America PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America PCSK9 Targeted Drugs Market Size by Country (2021-2026) & (US$ Million) Table 105. North America PCSK9 Targeted Drugs Market Share by Country (2021-2026) Table 106. North America PCSK9 Targeted Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America PCSK9 Targeted Drugs Market Share Forecast by Country (2027-2032) Table 108. Europe PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. Europe PCSK9 Targeted Drugs Sales by Country (2021-2026) & (K Units) Table 110. Europe PCSK9 Targeted Drugs Sales Market Share by Country (2021-2026) Table 111. Europe PCSK9 Targeted Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 112. Europe PCSK9 Targeted Drugs Sales Market Share Forecast by Country (2027-2032) Table 113. Europe PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe PCSK9 Targeted Drugs Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe PCSK9 Targeted Drugs Market Share by Country (2021-2026) Table 116. Europe PCSK9 Targeted Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe PCSK9 Targeted Drugs Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific PCSK9 Targeted Drugs Sales by Country (2021-2026) & (K Units) Table 120. Asia-Pacific PCSK9 Targeted Drugs Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific PCSK9 Targeted Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 122. Asia-Pacific PCSK9 Targeted Drugs Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific PCSK9 Targeted Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific PCSK9 Targeted Drugs Market Share by Country (2021-2026) Table 126. Asia-Pacific PCSK9 Targeted Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific PCSK9 Targeted Drugs Market Share Forecast by Country (2027-2032) Table 128. Latin America PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Latin America PCSK9 Targeted Drugs Sales by Country (2021-2026) & (K Units) Table 130. Latin America PCSK9 Targeted Drugs Sales Market Share by Country (2021-2026) Table 131. Latin America PCSK9 Targeted Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 132. Latin America PCSK9 Targeted Drugs Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America PCSK9 Targeted Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America PCSK9 Targeted Drugs Market Share by Country (2021-2026) Table 136. Latin America PCSK9 Targeted Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America PCSK9 Targeted Drugs Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa PCSK9 Targeted Drugs Sales by Country (2021-2026) & (K Units) Table 140. Middle East and Africa PCSK9 Targeted Drugs Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa PCSK9 Targeted Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 142. Middle East and Africa PCSK9 Targeted Drugs Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa PCSK9 Targeted Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa PCSK9 Targeted Drugs Market Share by Country (2021-2026) Table 146. Middle East and Africa PCSK9 Targeted Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa PCSK9 Targeted Drugs Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. PCSK9 Targeted Drugs Distributors List Table 151. PCSK9 Targeted Drugs Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. PCSK9 Targeted Drugs Image Figure 2. Global PCSK9 Targeted Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PCSK9 Targeted Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global PCSK9 Targeted Drugs Sales (2021-2032) & (K Units) Figure 5. Inclisiran Image Figure 6. Global Inclisiran Sales YoY Growth (2021-2032) & (K Units) Figure 7. Evolocumab Image Figure 8. Global Evolocumab Sales YoY Growth (2021-2032) & (K Units) Figure 9. Tafolecimab Image Figure 10. Global Tafolecimab Sales YoY Growth (2021-2032) & (K Units) Figure 11. Alirocumab Image Figure 12. Global Alirocumab Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global PCSK9 Targeted Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global PCSK9 Targeted Drugs Market Share by Type 2025 VS 2032 Figure 15. North America PCSK9 Targeted Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America PCSK9 Targeted Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe PCSK9 Targeted Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe PCSK9 Targeted Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific PCSK9 Targeted Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific PCSK9 Targeted Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America PCSK9 Targeted Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America PCSK9 Targeted Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa PCSK9 Targeted Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa PCSK9 Targeted Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 PCSK9 Targeted Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hypercholesterolemia Image Figure 28. Global Hypercholesterolemia Sales YoY Growth (2021-2032) & (K Units) Figure 29. Combined Hyperlipidemia Image Figure 30. Global Combined Hyperlipidemia Sales YoY Growth (2021-2032) & (K Units) Figure 31. Heart Disease and Stroke Prevention Image Figure 32. Global Heart Disease and Stroke Prevention Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global PCSK9 Targeted Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global PCSK9 Targeted Drugs Market Share by Application 2025 VS 2032 Figure 37. North America PCSK9 Targeted Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America PCSK9 Targeted Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe PCSK9 Targeted Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe PCSK9 Targeted Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific PCSK9 Targeted Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific PCSK9 Targeted Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America PCSK9 Targeted Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America PCSK9 Targeted Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa PCSK9 Targeted Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa PCSK9 Targeted Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America PCSK9 Targeted Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America PCSK9 Targeted Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America PCSK9 Targeted Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America PCSK9 Targeted Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe PCSK9 Targeted Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe PCSK9 Targeted Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe PCSK9 Targeted Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe PCSK9 Targeted Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific PCSK9 Targeted Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific PCSK9 Targeted Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific PCSK9 Targeted Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific PCSK9 Targeted Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America PCSK9 Targeted Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America PCSK9 Targeted Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America PCSK9 Targeted Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America PCSK9 Targeted Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa PCSK9 Targeted Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa PCSK9 Targeted Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa PCSK9 Targeted Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa PCSK9 Targeted Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. PCSK9 Targeted Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. PCSK9 Targeted Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Inclisiran
  • Evolocumab
  • Tafolecimab
  • Alirocumab
Applications
  • Hypercholesterolemia
  • Combined Hyperlipidemia
  • Heart Disease and Stroke Prevention
  • Other
Companies covered
  • Amgen
  • Regeneron Pharmaceuticals
  • Novartis
  • Sanofi
  • Innovent Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global PCSK9 Targeted Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global PCSK9 Targeted Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 PCSK9 Targeted Drugs Market by Type
  6. 1.3.1 Inclisiran
  7. 1.3.2 Evolocumab
  8. 1.3.3 Tafolecimab
  9. 1.3.4 Alirocumab
  10. 1.4 Global PCSK9 Targeted Drugs Market Size by Type
  11. 1.4.1 Global PCSK9 Targeted Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global PCSK9 Targeted Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global PCSK9 Targeted Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America PCSK9 Targeted Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe PCSK9 Targeted Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific PCSK9 Targeted Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America PCSK9 Targeted Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa PCSK9 Targeted Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 PCSK9 Targeted Drugs Industry Trends
  2. 2.2 PCSK9 Targeted Drugs Industry Drivers
  3. 2.3 PCSK9 Targeted Drugs Industry Opportunities and Challenges
  4. 2.4 PCSK9 Targeted Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by PCSK9 Targeted Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by PCSK9 Targeted Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by PCSK9 Targeted Drugs Price (2021-2026)
  4. 3.4 Global PCSK9 Targeted Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PCSK9 Targeted Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global PCSK9 Targeted Drugs Company, Product Type & Application
  7. 3.7 Global PCSK9 Targeted Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PCSK9 Targeted Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PCSK9 Targeted Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PCSK9 Targeted Drugs Tier 1, Tier 2, and Tier 3
4 PCSK9 Targeted Drugs Regional Status and Outlook
  1. 4.1 Global PCSK9 Targeted Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global PCSK9 Targeted Drugs Historic Market Size by Region
  3. 4.2.1 Global PCSK9 Targeted Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global PCSK9 Targeted Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global PCSK9 Targeted Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global PCSK9 Targeted Drugs Forecasted Market Size by Region
  7. 4.3.1 Global PCSK9 Targeted Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global PCSK9 Targeted Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global PCSK9 Targeted Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 PCSK9 Targeted Drugs by Application
  1. 5.1 PCSK9 Targeted Drugs Market by Application
  2. 5.1.1 Hypercholesterolemia
  3. 5.1.2 Combined Hyperlipidemia
  4. 5.1.3 Heart Disease and Stroke Prevention
  5. 5.1.4 Other
  6. 5.2 Global PCSK9 Targeted Drugs Market Size by Application
  7. 5.2.1 Global PCSK9 Targeted Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global PCSK9 Targeted Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global PCSK9 Targeted Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America PCSK9 Targeted Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe PCSK9 Targeted Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific PCSK9 Targeted Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America PCSK9 Targeted Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa PCSK9 Targeted Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Amgen
  2. 6.1.1 Amgen Company Information
  3. 6.1.2 Amgen Business Overview
  4. 6.1.3 Amgen PCSK9 Targeted Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Amgen PCSK9 Targeted Drugs Product Portfolio
  6. 6.1.5 Amgen Recent Developments
  7. 6.2 Regeneron Pharmaceuticals
  8. 6.2.1 Regeneron Pharmaceuticals Company Information
  9. 6.2.2 Regeneron Pharmaceuticals Business Overview
  10. 6.2.3 Regeneron Pharmaceuticals PCSK9 Targeted Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Regeneron Pharmaceuticals PCSK9 Targeted Drugs Product Portfolio
  12. 6.2.5 Regeneron Pharmaceuticals Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis PCSK9 Targeted Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis PCSK9 Targeted Drugs Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi PCSK9 Targeted Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi PCSK9 Targeted Drugs Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Innovent Biologics
  26. 6.5.1 Innovent Biologics Company Information
  27. 6.5.2 Innovent Biologics Business Overview
  28. 6.5.3 Innovent Biologics PCSK9 Targeted Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Innovent Biologics PCSK9 Targeted Drugs Product Portfolio
  30. 6.5.5 Innovent Biologics Recent Developments
7 North America by Country
  1. 7.1 North America PCSK9 Targeted Drugs Sales by Country
  2. 7.1.1 North America PCSK9 Targeted Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America PCSK9 Targeted Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America PCSK9 Targeted Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America PCSK9 Targeted Drugs Market Size by Country
  6. 7.2.1 North America PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America PCSK9 Targeted Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America PCSK9 Targeted Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe PCSK9 Targeted Drugs Sales by Country
  2. 8.1.1 Europe PCSK9 Targeted Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe PCSK9 Targeted Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe PCSK9 Targeted Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe PCSK9 Targeted Drugs Market Size by Country
  6. 8.2.1 Europe PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe PCSK9 Targeted Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe PCSK9 Targeted Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific PCSK9 Targeted Drugs Sales by Country
  2. 9.1.1 Asia-Pacific PCSK9 Targeted Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific PCSK9 Targeted Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific PCSK9 Targeted Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific PCSK9 Targeted Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific PCSK9 Targeted Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific PCSK9 Targeted Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America PCSK9 Targeted Drugs Sales by Country
  2. 10.1.1 South America PCSK9 Targeted Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America PCSK9 Targeted Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America PCSK9 Targeted Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America PCSK9 Targeted Drugs Market Size by Country
  6. 10.2.1 South America PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America PCSK9 Targeted Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America PCSK9 Targeted Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa PCSK9 Targeted Drugs Sales by Country
  2. 11.1.1 Middle East and Africa PCSK9 Targeted Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa PCSK9 Targeted Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa PCSK9 Targeted Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa PCSK9 Targeted Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa PCSK9 Targeted Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa PCSK9 Targeted Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa PCSK9 Targeted Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 PCSK9 Targeted Drugs Value Chain Analysis
  2. 12.1.1 PCSK9 Targeted Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 PCSK9 Targeted Drugs Production Mode & Process
  7. 12.2 PCSK9 Targeted Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 PCSK9 Targeted Drugs Distributors
  10. 12.2.3 PCSK9 Targeted Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst